7
Views
2
CrossRef citations to date
0
Altmetric
Review

Breast cancer associated with a concurrent or subsequent pregnancy

&
Pages 357-369 | Published online: 10 Jan 2014

References

  • Australian Institute of Health and Welfare and National Breast and Ovarian Cancer Centre. Breast cancer in Australia: an overview, 2009. Cancer series no. 50. Cat. no. CAN 46. Australian Institute of Health and Welfare, Canberra, Australia (2009).
  • Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur. J. Cancer39(18), 2632–2642 (2003).
  • Ives A, Semmens J, Saunders C, Puckridge P. Breast cancer and pregnancy: what we know and where we go. Cancer Forum26(2), 118–120 (2002).
  • Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer67(4), 869–872 (1991).
  • Phillips KA, Milne RL, Friedlander ML et al. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J. Clin. Oncol.22(4), 699–705 (2004).
  • Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. Br. Med. J.315(7112), 851–855 (1997).
  • Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol. Biomarkers Prev.11(3), 235–241 (2002).
  • Saunders C, Baum M. Breast cancer and pregnancy. J. R. Soc. Med.86, 162–165 (1993).
  • Nugent P, O’Connell TX. Breast cancer and pregnancy. Arch. Surg.120(11), 1221–1224 (1985).
  • Surbone A, Petrek J. Pregnancy after breast cancer. The relationship of pregnancy to breast cancer development and progression. Crit. Rev. Oncol. Hematol.27, 169–178 (1998).
  • Marchant DJ. Breast cancer in pregnancy. Clin. Obstet. Gynecol.37(4), 993–997 (1994).
  • Isaacs JH. Cancer of the breast in pregnancy. Surg. Clin. North Am.75(1), 47–51 (1995).
  • Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM. Pregnancy and breast cancer: a population-based study. Virchows Arch.443(1), 44–50 (2003).
  • Wallack MK, Wolf JA, Bedwinek J et al. Gestational carcinoma of the female breast. Curr. Probl. Cancer7(9), 1–58 (1983).
  • Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM. Breast cancer, pregnancy, and breastfeeding. J. Obstet. Gynaecol. Can.24(2), 164–180; quiz 181–184 (2002).
  • Berry DL, Theriault RL, Holmes FA et al. Management of breast cancer during pregnancy using a standardized protocol. J. Clin. Oncol.17(3), 855–861 (1999).
  • Loibl S, von Minckwitz G, Gwyn K et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer106(2), 237–246 (2006).
  • White TT. Carcinoma of the breast in the pregnant and nursing patient. Am. J. Obstet. Gynaecol.69, 1277–1286 (1955).
  • Ishida T, Yokoe T, Kasumi F et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case–control study in Japan. Jpn. J. Cancer Res.83(11), 1143–1149 (1992).
  • Gallenberg MM, Loprinzi CL. Breast cancer and pregnancy. Semin. Oncol.16(5), 369–376 (1989).
  • Bunker M, Peters M. Breast cancer associated with pregnancy or lactation. Am. J. Obstet. Gynecol.85, 312–321 (1963).
  • Applewhite RR, Smith LR, De Vincenti F. Carcinoma of the breast associated with pregnancy and lactation. Am. Surg.39, 101–104 (1973).
  • Treves N, Holleb AI. A report of 549 cases of breast cancer in women 35 years of age or younger. Surg. Gynecol. Obstet.107, 271 (1958).
  • Bonnier P, Romain S, Dilhuydy JM et al. Influence of pregnancy on the outcome of breast cancer: a case–control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int. J. Cancer72(5), 720–727 (1997).
  • Byrd BF, Bayer DS, Robertson JC et al. Treatment of breast tumors associated with pregnancy and lactation. Ann. Surg.155, 940–947 (1962).
  • National Breast and Ovarian Cancer Centre. The Investigation of a New Breast Symptom. A Guide for General Practitioners (2nd Edition). Sydney, Australia (2005).
  • Bernik S, Bernik T, Whooley B, Wallack M. Carcinoma of the breast during pregnancy: a review and update on treatment options. Surg. Oncol.7, 45–49 (1998).
  • Damrich D, Glasser G, Dolan M. The characteristics and evaluation of women presenting with a breast mass during pregnancy. Prim. Care Update Obs. Gyns.5(1), 21–23 (1998).
  • Gemignani M, Petrek J. Pregnancy associated breast cancer: diagnosis and treatment. Breast J.6(1), 68–73 (2000).
  • Ahn BY, Kim HH, Moon WK et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J. Ultrasound Med.22(5), 491–497; quiz 498–499 (2003).
  • Liberman L, Giess CS, Dershaw DD, Deutch BM, Petrek JA. Imaging of pregnancy-associated breast cancer. Radiology191(1), 245–248 (1994).
  • Max MH, Klamer TW. Pregnancy and breast cancer. South Med. J.76(9), 1088–1090 (1983).
  • Samuels TH, Liu FF, Yaffe M, Haider M. Gestational breast cancer. Can. Assoc. Radiol. J.49(3), 172–180 (1998).
  • Pisano ED, Gatsonis C, Hendrick E et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N. Engl. J. Med.353(17), 1773–1783 (2005).
  • Kanal E, Borgstede J, Barkovich A et al. American College of Radiology White Paper on MR Safety: 2004 Update and Revisions. AJR Am. J. Roentgenol.182, 1111–1114 (2004).
  • Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology244(3), 672–691 (2007).
  • Heywang-Kobrunner S, Schereer I, Dershaw D. Differential diagnosis and diagnostic work up and the young patient. In: Diagnostic Breast Imaging: Mammography, Sonography, Magnetic Resonance Imaging and Interventional Procedures. Heywang-Kobrunner S, Schereer I, Dershaw D (Eds). Thieme, NY, USA (1997).
  • Talele AC, Slanetz PJ, Edmister WB, Yeh ED, Kopans DB. The lactating breast: MRI findings and literature review. Breast J.9(3), 237–240 (2003).
  • Novotny DB, Maygarden SJ, Shermer RW, Frable WJ. Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol.35(6), 676–686 (1991).
  • Petrek JA. Breast cancer during pregnancy. Cancer74(1 Suppl.), 518–527 (1994).
  • Gemignani M, Petrek J, Brogen P. Breast cancer and pregnancy. Surg. Clin. North Am.79(5), 1157–1169 (1999).
  • Gwyn K, Theriault R. Breast cancer during pregnancy. Oncology (Williston Park)15(1), 39–46 (2001).
  • Holleb AI, Farrow JH. The relation of carcinoma of the breast and pregnancy in 283 patients. Surg. Gynecol. Obstet.115, 65–71 (1962).
  • King RM, Welch JS, Martin JK Jr, Coulam CB. Carcinoma of the breast associated with pregnancy. Surg. Gynecol. Obstet.160(3), 228–232 (1985).
  • Shousha S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch. Pathol. Lab. Med.124(7), 1053–1060 (2000).
  • Reed W, Sandstad B, Holm R, Nesland JM. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int. J. Surg. Pathol.11(2), 65–74 (2003).
  • Aziz S, Pervez S, Khan S et al. Case–control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol. Res. Pract.199(1), 15–21 (2003).
  • Gentilini O, Masullo M, Rotmensz N et al. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur. J. Surg. Oncol.31(3), 232–236 (2005).
  • Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch. Surg.138(1), 91–98; discussion 99 (2003).
  • Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer98(5), 1055–1060 (2003).
  • Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J. Clin. Oncol.23(18), 4192–4197 (2005).
  • Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br. J. Surg.73(8), 607–609 (1986).
  • Anderson JM. Inflammatory carcinomas of the breast. Ann. R. Coll. Surg. Engl.62(3), 195–199 (1980).
  • Clark RM, Reid J. Carcinoma of the breast in pregnancy and lactation. Int J. Radiat. Oncol. Biol. Phys.4(7–8), 693–698 (1978).
  • Petrek JA. Breast cancer and pregnancy. J. Natl Cancer Inst. Monogr.16, 113–121 (1994).
  • Ring AE, Smith IE, Ellis PA. Breast cancer and pregnancy. Ann. Oncol.16(12), 1855–1860 (2005).
  • Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer71(8), 2499–2506 (1993).
  • Shen T, Vortmeyer AO, Zhuang Z, Tavassoli FA. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma. J. Natl Cancer Inst.91(19), 1686–1687 (1999).
  • Johannsson O, Loman N, Borg A, Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet352(9137), 1359–1360 (1998).
  • Rosner D, Yeh J. Breast cancer and related pregnancy: suggested management according to stages of the disease and gestational stages. J. Med.33(1–4), 23–62 (2002).
  • Kal HB, Struikmans H. Breast cancer and pregnancy. Breast17(1), 7 (2008).
  • Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol.5(5), 283–291 (2004).
  • Reichman BS, Green KB. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. J. Natl Cancer Inst. Monogr.16, 125–129 (1994).
  • Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med.152(3), 573–576 (1992).
  • Williams SF, Schilsky RL. Antineoplastic drugs administered during pregnancy. Semin. Oncol.27(6), 618–622 (2000).
  • Halaska MJ, Pentheroudakis G, Strnad P et al. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J.15(5), 461–467 (2009).
  • Pan PH, Moore CH. Doxorubicin-induced cardiomyopathy during pregnancy: three case reports of anesthetic management for cesarean and vaginal delivery in two kyphoscoliotic patients. Anesthesiology97(2), 513–515 (2002).
  • Andreadis C, Charalampidou M, Diamantopoulos N, Chouchos N, Mouratidou D. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. Gynecol. Oncol.95(1), 252–255 (2004).
  • Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast13(6), 446–451 (2004).
  • De Santis M, Lucchese A, De Carolis S, Ferrazani S, Caruso A. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur. J. Cancer Care (Engl.)9(4), 235–237 (2000).
  • Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin. Breast Cancer6(4), 354–356 (2005).
  • Gonzalez-Angulo AM, Walters RS, Carpenter RJ Jr et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin. Breast Cancer5(4), 317–319 (2004).
  • Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet. Gynecol.105(3), 642–643 (2005).
  • Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol.8(1), 79–81 (2007).
  • Berveiller P, Mir O, Sauvanet E, Antoine EC, Goldwasser F. Ectopic pregnancy in a breast cancer patient receiving trastuzumab. Reprod. Toxicol.25(2), 286–288 (2008).
  • Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL. Treatment of breast cancer with trastuzumab during pregnancy. J. Clin. Oncol.26(9), 1567–1569 (2008).
  • Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet. Gynecol.110(2 Pt 2), 507–510 (2007).
  • Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Favorable pregnancy outcome following trastuzumab (herceptin) use during pregnancy – case report and updated literature review. Reprod. Toxicol.23(4), 611–613 (2007).
  • Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G. Trastuzumab treatment for breast cancer during pregnancy. Can. Fam. Physician54(1), 31–32 (2008).
  • Waterston AM, Graham J. Effect of adjuvant trastuzumab on pregnancy. J. Clin. Oncol.24(2), 321–322 (2006).
  • Witzel ID, Muller V, Harps E, Janicke F, Dewit M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann. Oncol.19(1), 191–192 (2008).
  • Cullins SL, Pridjian G, Sutherland CM. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. JAMA271(24), 1905–1906 (1994).
  • Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med. Pediatr. Oncol.16(1), 3–6 (1988).
  • Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J.16(1), 76–82 (2010).
  • Clark R, Chua T. Breast cancer and pregnancy: the ultimate challenge. Clin. Oncol.1, 11–18 (1989).
  • DiFronzo LA, O’Connell TX. Breast cancer in pregnancy and lactation. Surg. Clin. North Am.76(2), 267–278 (1996).
  • Guinee VF, Olsson H, Moller T et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet343(8913), 1587–1589 (1994).
  • Ezzat A, Raja MA, Berry J et al. Impact of pregnancy on non-metastatic breast cancer: a case–control study. Clin. Oncol.8(6), 367–370 (1996).
  • Ives A. Breast Cancer and Pregnancy: How Does a Concurrent or Subsequent Pregnancy Affect Breast Cancer Diagnosis, Management and Outcomes? The University of Western Australia, WA, Australia (2009).
  • Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast12(6), 516–521 (2003).
  • Lethaby AE, O’Neill MA, Mason BH, Holdaway IM, Harvey VJ. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int. J. Cancer67(6), 751–755 (1996).
  • Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J. Clin. Oncol.27(1), 45–51 (2009).
  • Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol. Biomarkers Prev.15(1), 65–69 (2006).
  • Donegan WL. Breast cancer and pregnancy. Obstet. Gynecol.50(2), 244–252 (1977).
  • Kroman N, Jensen M, Wolfahrt J, Mouridsen H. Should women be advised against pregnancy after breast-cancer treatment? Lancet350, 319–322 (1997).
  • Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: ‘healthy mother effect’. Am. J. Obstet. Gynecol.170(3), 818–823 (1994).
  • Ribeiro GG, Palmer MK. Breast carcinoma associated with pregnancy: a clinician’s dilemma. Br. Med. J.2(6101), 1524–1527 (1977).
  • Harvey JC, Rosen PP, Ashikari R, Robbins GF, Kinne DW. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy. Surg. Gynecol. Obstet.153, 723–725 (1981).
  • Peters MV. The effect of pregnancy in breast cancer. In: Prognostic Factors in Breast Cancer. Forrest APM, Kunkler PB. (Eds). Williams and Wilkins, MD, USA, 65–80 (1968).
  • Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer65(4), 847–850 (1990).
  • Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. Br. Med. J.334(7586), 194 (2007).
  • Moore HCF, Foster RS Jr. Breast cancer and pregnancy. Semin. Oncol.27(6), 646–653 (2000).
  • Two cases of breast cancer in young women. Eur. J. Surg. Oncol.22(1), 108–113 (1996).
  • Holmberg L, Anderson H. HABITS (Hormonal Replacement Therapy After Breast Cancer – Is It Safe?), a randomised comparison: trial stopped. Lancet363(9407), 453–455 (2004).
  • Surbone A, Petrek JA. Childbearing issues in breast carcinoma survivors. Cancer79(7), 1271–1278 (1997).
  • Gadducci A, Cosio S, Genazzani AR. Ovarian function and childbearing issues in breast cancer survivors. Gynecol. Endocrinol.23(11), 625–631 (2007).
  • Petrek JA, Naughton MJ, Case LD et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J. Clin. Oncol.24(7), 1045–1051 (2006).
  • Richards MA, O’Reilly SM, Howell A et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy’s/Manchester trial. J. Clin. Oncol.8(12), 2032–2039 (1990).
  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet365(9472), 1687–1717 (2005).
  • Bao T, Davidson NE. Adjuvant endocrine therapy for premenopausal women with early breast cancer. Breast Cancer Res.9(6), 115 (2007).
  • Recchia F, Saggio G, Amiconi G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer106(3), 514–523 (2006).
  • Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum. Reprod. Update14(6), 543–552 (2008).
  • Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res. Treat.117(3), 561–567 (2009).
  • Clowse ME, Behera MA, Anders CK et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J. Womens Health (Larchmt)18(3), 311–319 (2009).
  • Meadors B, Robinson D. Fertility options after cancer treatment: a case report and literature review. Prim. Care Update Ob. Gyns.9(1), 51–54 (2002).
  • Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod.18(1), 90–95 (2003).
  • Lee SJ, Schover LR, Partridge AH et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18), 2917–2931 (2006).
  • Bloom JR, Stewart SL, Johnston M, Banks P, Fobair P. Sources of support and the physical and mental well-being of young women with breast cancer. Soc. Sci. Med.53(11), 1513–1524 (2001).
  • Coyne E, Borbasi S. Holding it all together: breast cancer and its impact on life for younger women. Contemp. Nurse23(2), 157–169 (2006).
  • Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur. J. Cancer40(5), 673–680 (2004).
  • Mor V, Allen S, Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer74(7 Suppl.), 2118–2127 (1994).
  • Dunn J, Steginga S. Young women’s experience of breast cancer: defining young and identifying concerns. Psychooncology9(2), 137–146 (2000).
  • Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ. Psychosocial issues confronting young women with breast cancer. Breast Dis.23, 103–113 (2005).
  • Thewes B, Meiser B, Rickard J, Friedlander M. The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology12(5), 500–511 (2003).
  • Thewes B, Butow P, Girgis A, Pendlebury S. The psychosocial needs of breast cancer survivors; a qualitative study of the shared and unique needs of younger versus older survivors. Psychooncology13(3), 177–189 (2004).
  • Thewes B, Meiser B, Duric VM et al. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol.6(8), 581–588 (2005).
  • Thewes B, Meiser B, Taylor A et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J. Clin. Oncol.23(22), 5155–5165 (2005).
  • Northouse LL, Dorris G, Charron-Moore C. Factors affecting couples’ adjustment to recurrent breast cancer. Soc. Sci. Med.41(1), 69–76 (1995).
  • Gluhoski V, Siegal K, Gorey E. Unique stressors experienced by unmarried women with breast cancer. J. Psychosoc. Oncol.15(3–4), 173–183 (1997).
  • Eisinger F, Noizet A. Breast cancer and pregnancy: decision making and the point of view of the mother. Bull. Cancer89(9), 755–757 (2002).
  • Schover LR. Psychosocial issues associated with cancer in pregnancy. Semin. Oncol.27(6), 699–703 (2000).
  • Zanetti-DAllenbach R, Tschudin S, Lapaire O, Holzgreve W, Wight E, Bitzer J. Psychological management of pregancy-related breast cancer. Breast15(52), S53–S59 (2006).
  • Barnes J, Kroll L, Burke O, Lee J, Jones A, Stein A. Qualitative interview study of communication between parents and children about maternal breast cancer. West. J. Med.173(6), 385–389 (2000).
  • Turner J. Children’s and family needs of young women with advanced breast cancer: a review. Palliat. Support. Care2(1), 55–64 (2004).
  • Barnes J, Kroll L, Lee J, Burke O, Jones A, Stein A. Factors predicting communication about the diagnosis of maternal breast cancer to children. J. Psychosom. Res.52(4), 209–214 (2002).
  • Turner J, Kelly B, Swanson C, Allison R, Wetzig N. Psychosocial impact of newly diagnosed advanced breast cancer. Psychooncology14(5), 396–407 (2005).
  • Hoke LA. Psychosocial adjustment in children of mothers with breast cancer. Psychooncology10(5), 361–369 (2001).
  • Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psychooncology15(7), 579–594 (2006).
  • Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur. J. Cancer36(15), 1938–1943 (2000).
  • Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur. J. Surg. Oncol.25(6), 571–573 (1999).
  • Schover LR. Sexuality and body image in younger women with breast cancer. J. Natl Cancer Inst. Monogr.1994(16), 177–182 (1994).
  • Northouse LL. The impact of breast cancer on patients and husbands. Cancer Nurs.12(5), 276–284 (1989).
  • Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer86(4), 697–709 (1999).
  • Siegel K, Gorey E, Gluhoski V. Pregnancy decision making among women previously treated for breast cancer. J. Psychosoc. Oncol.15(1), 27–42 (1997).

Website

  • Horner MJ, Ries LAG, Krapcho M et al. SEER Cancer Statistics Review, 1975–2006. Based on November 2008 SEER data submission, posted to the SEER website, 2009. National Cancer Institute, Bethesda, MD, USA (2009). http://seer.cancer.gov/csr/1975_2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.